Enochian BioSciences (RENB) - Yalpi rentabellik

RENB (Renovaro) - kompaniyaning tovar belgisi

IT-texnologiyalar asosidagi dori vositalarini kashf etish imkoniyati tufayli og'ir ishlab chiqarish zavodlarining yo'qligi Renovaro Inc. (RENB) biznesini ekologik barqaror qiladi. GURU.Markets terminalining chiziqli grafigidagi yalpi foyda marjasidagi o'zgarish 0.00 qiymatiga ega bo'lib, u ushbu metrikaning joriy darajasini ifodalaydi. Bu immunoterapiya konveyerining kengayish strategiyasini hamda hujayraviy vaksinalarni o'smalarni erta aniqlash uchun yuqori texnologiyali diagnostika bilan integratsiya qiluvchi yopiq ekotizim yaratilishini tasdiqlaydi.

Enochian BioSciences (RENB) Yalpi rentabellik: 21.02.2024 - 01.10.2025 davri uchun

Enochian BioSciences (RENB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:RENB - renovarobio.com
Renovaro Biosciences brend mahsuloti

Renovaro Inc. tadqiqot va ishlanmalar (R&D) startapi sifatida faoliyat yuritadi, bunda tijorat mahsulotlarining yo'qligi kompaniyani tashqi moliyalashtirishga bog'liq qiladi. Bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyin qolgan daromad sifatida hisoblanadigan joriy yalpi foyda, ushbu modelda kapitalni boshqarish samaradorligining va klinik sinovlar bosqichida xarajatlarni minimallashtirish qobiliyatining ko'rsatkichi bo'lib xizmat qiladi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik